A Prospective Duplex Doppler Ultrasonographic Study in Women with Sexual Arousal Disorder to Objectively Assess Genital Engorgement Induced by EROS Therapy

The EROS therapy device is FDA-approved for the treatment of women with sexual dysfunction and has been shown to improve sexual function and satisfaction. The aim of this study was to obtain objective information regarding the ability of the EROS Therapy device to induce clitoral and corpus spongios...

Full description

Saved in:
Bibliographic Details
Published inJournal of sex & marital therapy Vol. 29; no. sup1; pp. 85 - 94
Main Authors MUNARRIZ, RICARDO, MAITLAND, SCOTT, GARCIA, SANDRA P., TALAKOUB, LILY
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Informa UK Ltd 01.01.2003
Human Sciences Press
Subjects
Adult
Biological and medical sciences
Clitoris - blood supply
Female
Hemodynamics - physiology
Humans
Medical sciences
Middle Aged
Miscellaneous
Prospective Studies
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Severity of Illness Index
Sexual Dysfunctions, Psychological - diagnostic imaging
Sexual Dysfunctions, Psychological - therapy
Surveys and Questionnaires
Treatments
Ultrasonography, Doppler, Duplex - methods
Sonography
Human
Clitoris
Orgasm
Sexual behavior disorder
Volume
Treatment efficiency
Sexuality
Medical imagery
Female
Personality
Duplex ultrasonography
Online AccessGet full text
ISSN0092-623X
1521-0715
DOI10.1080/713847133

Cover

More Information
Summary:The EROS therapy device is FDA-approved for the treatment of women with sexual dysfunction and has been shown to improve sexual function and satisfaction. The aim of this study was to obtain objective information regarding the ability of the EROS Therapy device to induce clitoral and corpus spongiosum volumetric and hemodynamic changes following therapeutic use in women with sexual arousal disorder. Seven patients with sexual arousal disorder formed the study population. All seven subjects met inclusion and exclusion criteria, including having normal hormonal values at the time of the study. All seven subjects were able to comfortably operate the device. All seven reported either slight-to-moderate pleasure or orgasm at home with the device. We observed no adverse events. This study shows that EROS therapy is associated with significant increases in clitoral and corpus spongiosum diameter as well as with clitoral and corpus spongiosum peak systolic and enddiastolic velocity values.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0092-623X
1521-0715
DOI:10.1080/713847133